Silencing and Nuclear Repositioning of the λ5 Gene Locus at the Pre-B Cell Stage Requires Aiolos and OBF-1

• Alexander Karnowski,

  Affiliations Friedrich Miescher Institute for Biomedical Research, Novartis Research Foundation, Basel, Switzerland, The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia

  ⨯
• Chun Cao,

  Affiliation Friedrich Miescher Institute for Biomedical Research, Novartis Research Foundation, Basel, Switzerland

  ⨯
• Gabriele Matthias,

  Affiliation Friedrich Miescher Institute for Biomedical Research, Novartis Research Foundation, Basel, Switzerland

  ⨯
• Sebastian Carotta,

  Affiliation The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia

  ⨯
• Lynn M. Corcoran,

  Affiliation The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia

  ⨯
• Inga-Lill Martensson,

  Affiliation Laboratory of Lymphocyte Signaling and Development, The Babraham Institute, Cambridge, United Kingdom

  ⨯
• Jane A. Skok,

  Affiliations Department of Immunology and Molecular Pathology, University College London, London, United Kingdom, New York University School of Medicine, New York, New York, United States of America

  ⨯
• Patrick Matthias

  * E-mail: patrick.matthias@fmi.ch

  Affiliation Friedrich Miescher Institute for Biomedical Research, Novartis Research Foundation, Basel, Switzerland

  ⨯